Author Guidelines

1.  Article types for publication in Blood borne infections (BBI) journal

2.  Editorial and Publishing policies

    2.1. Peer review policy

    2.2. Authorship

    2.3. Acknowledgements

    2.4. Funding

    2.5. Declaration of conflicting interests

    2.6. Experimental and publication ethics

    2.7. Open access publication

3.  Preparing manuscript

    3.1. Word processing formats

    3.2. Artwork, figures and other graphics

    3.3. Supplementary material

    3.4. Reference style

    3.5. English language editing services

4.  Submitting manuscript

    4.1. How to submit your manuscript

    4.2. Corresponding author contact details

5.  On acceptance and publication

    5.1. Access to your published article

    5.2. Online first publication

6.  Further information

Blood borne infections (BBI) is a pending member of the Committee on Publication Ethics (COPE).

Please read the guidelines below then visit the Journal’s submission site http://www.bbijournal.com/index.php/bbi/pages/view/submit to upload manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

Only manuscripts of sufficient quality that meet the aims and scope of the BBI will be reviewed.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

1. Article types for publication in the BBI (Journal)

BBI publishes original research, review articles, short communications and letters that cover different issues of transfusion-transmitted viral infections as well as sexually-transmitted diseases such as epidemiology, pathogenesis, clinical outcomes, diagnosis, management, prevention and screening.

Focusing areas are including, but not limited to, Hepatitis B, Hepatitis C, Hepatitis D, HIV/AIDS, HTLV-1 and HTLV-2 infections, HPV infection, HSV genital infection and the related high-risk behaviors.

Types of papers Considered for Publication

All manuscripts must be typewritten in a font size of 12 points, double-spaced (including References, Tables and Figure legends) with wide margins (2.5 cm from all sides) on papers. The beginning of each new paragraph must clearly be indicated by indentation. All pages should be numbered consecutively at the bottom starting with the title page. Each type of articles should have specific requirements as follow:

  • Research Articles: Should be no longer than 4000 words in length including references (but not figures or tables) and up to 45 references.
  • Short Communications: brief papers (1000-1500 words) making a specific well-documented point.
  • Reviews: (usually 5000 words of text; excluding references, figures or tables and up to 150 references) state-of-the-art overviews of hot topics and developments often commissioned. Concise reviews, invited reviews and meta-analysis should follow the same rules for reviews.
  • Hypothesis/Ideas: manuscripts (2000 words or less) that present an original hypothesis or an innovative idea. The article should set out a clearly identified hypothesis that can be supported by appropriate references justifying the validity of the hypothesis. The article should propose what experimental work might test the hypothesis, but should not contain new data of an experimental nature unless essential.
  • Commentaries/Perspectives/Opinions: Short notes or letters (no more than 1000 words in length) commentating on papers published in the Journal. Perspectives or opinions giving a viewpoint on the already being applied methodologies, protocols, data or highlighting the critical issues in blood borne infections research can also be presented.
  • Editorials/Letters: While guest editorials are preponderantly solicited, persons interested in contributing editorials from the editorial or reviewer board members and letters from the authors or readers are encouraged to contact the Editor.

2. Editorial policies

2.1. Peer review policy

BBI operates a conventional blind reviewing policy in which the reviewer’s names are always concealed from the submitting author. First, all manuscripts are carefully reviewed by the Editors and only those papers that meet the scientific and editorial standards and fit within the aims and scope of the journal will be sent for reviewing. BBI has its own editorial and reviewer board for pre- and final evaluation of manuscript regarding the technical and scientific quality, respectively.

Authors are requested to suggest the names, affiliations and contact information of up to three individuals who may be suitable to serve as referees, but the Editors are under no obligation to use all or any of these individuals as reviewers.

Peer Review Process: We endeavor to obtain at least 2 referee’s reports. All manuscripts are reviewed as soon as possible, and an editorial decision is generally reached within 5-6 weeks of submission.

As part of the submission process you will be asked to provide the names of 2-3 peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below: 

  • The reviewer's knowledge of your submission
  • The reviewer's recently collaboration with any of the authors
  • Reviewer nominees from the same institution as any of the authors are not permitted

Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.

 2.2. Authorship

BBI endorses the Vancouver Guidelines on authorship as defined in the International Committee of Medical Journal Editors' (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals, namely that entitlement to authorship should be based on all of the following criteria: (1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it for important intellectual content; (3) final approval of the version to be published. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements.

Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

 2.3. Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section.

Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

2.4. Funding

BBI requires all authors to acknowledge their funding in the form of a sentence with the full name of the funding agency followed by the grant number in square brackets.

2.5. Declaration of conflicting interests

Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

For guidance on conflict of interest statements, please see the ICMJE recommendations here.

2.6. Experimental and publishing ethics

2.6.1. Experimental ethics

BBI asks authors to certify that all animals utilized in their research were cared for according to the policies and principles established by the Animal Welfare Act and the NIH Guide for Care and Use of Laboratory Animals.  Experiments with animals should be performed in accordance with the legal requirements of the relevant local or national authority. Procedures should be such that experimental animals do not suffer unnecessarily. The text of papers should include details of the strain or stock of animal used, experimental procedures, and of anesthetics used. It is recommended that authors refer to the 'ARRIVE' Guidelines on the reporting of animal research.

Papers describing any experimental work with humans should include a statement that the research has been carried out in accordance with the Declaration of Helsinki (2008) of the World Medical Association, that the Ethical Committee of the Institution in which the work was performed has approved it, and that the subjects have given written informed consent to the work.

The Editorial Board will not accept papers where the ethical aspects are, in the Board's opinion, open to doubt.

iMaQ Publishing Corporation (International) endorses the guidelines published by COPE (Committee on Publication Ethics) and will always investigate fully any matters of apparent misconduct that it becomes aware of.

BBI as a part of iMaQ Publishing Corporation follows the guidelines published by COPE in respect of the retraction of articles.

2.6.2. Publication Ethics Statement (Plagiarism)

We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors.

We take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice.

Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

2.7. Open access publication

BBI is a peer-reviewed, open access journal, which means that all published articles are made freely available online without a subscription, and authors retain the copyright of their work.

Article Processing Charges (APCs): Blood borne infections (Journal) is not charging any kind of fee and all submitted manuscripts will be processed free of charge.

3. Preparing manuscript

3.1. Manuscript format and Order of contents

Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 2.5 cm from all sides. Text should be standard 12 point, and  number all pages consecutively. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

Your manuscript should be written in clear, concise, and grammatically correct International English; manuscripts that are inadequately prepared in the required format of the journal will be declined, since it is not feasible for the Editors to undertake extensive revision or rewriting of manuscripts.

Title page: This should contain the following:
  • Article title
  • Name(s) of author(s) (with first or second given name spelled out in full)
  • Author affiliation(s)
  • Short running title (abbreviated form of title): no more than 65 characters including spaces and punctuations.
  • Name and complete mailing address (including telephone and fax numbers and email address) of the person to whom correspondence should be sent.
  • Up to eight key words (in alphabetical order), of which at least three do not appear in the title of the paper.
  • List of abbreviations used (no need to list standard abbreviations such as DNA, RNA, etc; use SI units wherever possible)

The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting here for guidelines on How to Help Readers Find Your Article Online.

 Abstract: A structured abstract with the following sections: Background, Methods, Results and Conclusion. The entire Abstract should not be more than 300 words; no subheadings, not included in section numbering, this must be concise and factual, and able to stand alone.

 Subdivision: divide your paper into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, etc).

  1. Introduction: the objectives of the work should be stated and an adequate background provided; avoid a detailed literature survey or a summary of the results.
  2. Materials and methods: provide sufficient detail to allow the work to be reproduced; methods already published should be indicated by a reference and only relevant modifications described.
  3. Results: this section should be clear and concise, and may be combined with the Discussion section if appropriate
  4. Discussion: this section should explore the significance of the results, not repeat them; extensive citations and discussion of published literature should be avoided.
  5. Conclusions: the main conclusions may be presented in this short section, which may stand alone or form a subsection of the Discussion section.

Acknowledgements: list those individuals who provided assistance during the research or provided help with the writing of the article.

Funding: in the form of a sentence with the full name of the funding agency followed by the grant number in square brackets.

Declaration of conflicting interests: Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

  References should be followed as explained in Section 3.4 (Reference style).

 Tables with their titles

 Figure Legends

 Figures

Please be sure to submit your illustrations and tables as separate files. The system will automatically create a pdf file of your paper for the reviewers.

3.2. Artwork, figures and other graphics

3.2.1. Preparing figures

Figures should be embedded in the manuscript and submitted together as one file for review. If the manuscript accepted, the original figures might be required. The Figures in PNG, TIFF, JPG, EPS, PDF or PSD formats are allowed. All figures must be over 300 dots-per-pixel (dpi) as per the requirements of PubMed Central (PMC). Color figures are encouraged to enhance the presentation of the data, without any charge.

The parts of multi-part figures (i.e., figures with parts labeled a, b, c, d, etc.) should be assembled into a single figure that fits on one page and presented as a single file.

Figures should be properly sized and cropped so that no unnecessary white space is left bordering the figure. The maximum height should be 6 inches (15 cm). Choose letters and numbers with the appropriate proportion and size, with the smallest type size more than 2 mm. Times New Roman or Arial are recommended fonts in figures.

BBI will be published in an online-only format. Thus, Figures supplied in colour will appear in colour online.

Figure legends

For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals, viz. Figure 1, 2, 3, etc); short title of figure (15 words or less); detailed legend (up to 300 words), a description of the figure to allow readers to understand the figure without referring to the text. The legend itself should be succinct; avoid lengthy descriptions of methods. Define all non-standard symbols and abbreviations. Legends should be organized consecutively in a separate section of the manuscript. Indicate the figure number on each figure.

 3.2.2. Preparing tables

  • Tables should be numbered with Arabic numbers. Cite the tables in the text in consecutive numerical order. Tables should be grouped at the end of the manuscript on separate pages.
  • Tables should have concise titles and sufficient experimental detail in a foot note immediately below the title to be understood without reference to the text.
  • Each column in a table must have a heading.
  • Abbreviations, when necessary, should be defined in the legend.
  • Footnotes to tables should be indicated by superscript lower case letters (or asterisks for significance values and other statistical data) and included below the table body.
  • Color and shading may be used; parts of the table can be highlighted using symbols or bold text, the meaning of which should be explained in the table legend.
  • Larger datasets or tables too wide for a landscape page can be uploaded separately as additional files. Additional files will not be displayed in the final, laid-out PDF of the article, but a link will be provided to the files as supplied by the author.
  • Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls) or comma separated values (.csv). As with all files, please use the standard file extensions.

 3.3. Supplementary material

BBI is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page. 

3.4. Reference style

BBI adheres to the  Vancover stylee style. To review the guidelines and samples on  reference style to ensure your manuscript conforms to this reference style. If you use EndNote to manage references, you can download the reference style output file and if you use Mendeley you can download the  reference style output file.

3.5. English language editing services

Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using iMaQ Language Services.

 

4. Submitting manuscript

4.1. How to submit manuscript

BBI is hosted by DiscoverSys Inc., a web based online submission and peer review system powered by eJournals. Visit http://bbijournal.com/index.php/bbi/login to login and submit your article online.

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.

4.2. Corresponding author contact details

Provide full contact details for the corresponding author including email, mailing address and telephone numbers. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

5. On acceptance and publication

5.1. Access to your published article

The iMaQ Production Department will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors will provide with online access to their final article.

5.2. Online First publication

Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication.

6. Further information

Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the BBI editorial office as follows:

BBI Editorial Office
Email address: editor@bbijournal.com